Urokinase-type plasminogen activator (uPA) is a 55-kDa serine protease that activates plasminogen to plasmin leading to cell matrix degradation, which is involved in tumor cell adhesion, migration, invasion and intravasation (5). This evidence concerns the gene PLG and neoplasm.